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CYC1 Silencing Sensitizes Osteosarcoma Cells to TRAIL-Induced Apoptosis
the effects of CYC1 silencing on TRAIL-induced apoptosis in human OS in vitro and in vivo along with the underlying mechanisms. Methods: First, we determined the expression of CYC1 in human OS tumors and cell lines versus normal adjacent tissues and cell line. We then studied the effects of CYC1 silencing alone or in combination with TRAIL on OS cell growth and apoptosis in vitro and OS tumorigenesis in vivo. Results: We found that CYC1 is overexpressed in human OS tissues and cell lines. CYC1 silencing by shRNA transfection inhibits proliferation, slightly induces apoptosis in human OS cells in vitro, and suppresses human OS tumor growth in a mouse xenograft model in vivo. Additionally, CYC1 silencing sensitizes OS to TRAIL-induced apoptosis in vitro and in vivo. Our results also showed that cytochrome c release and caspase-9 activation in OS cells, suggesting that CYC1 silencing acts via the mitochondria-dependent apoptotic pathway. Conclusion: Taken together, our results provide evidence that CYC1 plays an important role in OS tumorigenesis, and modulation of CYC1 may be an effective strategy to potentiate OS to apoptotic induction by TRAIL.
Introduction
Osteosarcoma (OS) is the most common malignant bone tumor affecting children and adolescents [1] . Current standard treatment is to use neoadjuvant chemotherapy (chemotherapy given before surgery) followed by surgical resection [2] . However, owing to resistant to commonly used chemotherapeutic agents [3] , OS has one of the lowest survival considered to overcome thermotherapy resistance in the treatment of OS in order to improve the clinical outcome in patients.
which in turn initiate a cascade of events resulting in stimulation of the extrinsic apoptotic and induction of apoptosis requires combination treatment with other chemotherapeutic cytochrome bc1 complex), which forms the third proton pump in the mitochondrial electron transport chain. CYC1 directly interacts with cytochrome c (Cytc) and mediates electron transport from cytochrome B to Cytc addition to OS, CYC1 has also been found to be overexpressed in nasopharyngeal carcinoma mitochondrial function and enhances Cytc through promoting Cytc on OS cell growth and apoptosis in vitro and OS tumorigenesis in vivo, either alone or in
Materials and Methods

Clinical specimens
Human OS and matched adjacent normal tissues (n = 30) were obtained from patients at Shanghai Cell Physiol Biochem 2014; 34:2070 -2080 
